Published in J Cell Biochem on January 01, 2002
Soluble cadherins as cancer biomarkers. Clin Exp Metastasis (2007) 1.20
P-cadherin expression in breast cancer: a review. Breast Cancer Res (2007) 1.09
Adhesion in mammary development: novel roles for E-cadherin in individual and collective cell migration. Curr Top Dev Biol (2015) 0.85
Expression of podoplanin and classical cadherins in salivary gland epithelial cells of klotho-deficient mice. Acta Histochem Cytochem (2011) 0.84
Cadherin cell adhesion system in canine mammary cancer: a review. Vet Med Int (2012) 0.82
The expression of podoplanin and classic cadherins in the mouse brain. J Anat (2012) 0.81
P-cadherin and the journey to cancer metastasis. Mol Cancer (2015) 0.80
P-cadherin expression in canine lactating mammary gland. J Cell Biochem (2002) 0.78
E-cadherin roles in animal biology: A perspective on thyroid hormone-influence. Cell Commun Signal (2016) 0.75
Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas. BMC Vet Res (2014) 0.75
SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature (2008) 4.27
Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta (2006) 2.76
The protective role of pregnancy in breast cancer. Breast Cancer Res (2005) 1.95
The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol (2006) 1.94
Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol (2005) 1.94
In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat. Environ Health Perspect (2010) 1.75
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol (2003) 1.66
17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J (2006) 1.50
Development of the human breast. Maturitas (2004) 1.50
Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim Biophys Acta (2012) 1.44
Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol (2006) 1.41
ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches. Biochim Biophys Acta (2009) 1.41
Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats. Environ Health Perspect (2009) 1.38
MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J Exp Med (2005) 1.34
The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice. Cancer Epidemiol Biomarkers Prev (2003) 1.26
Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res (2007) 1.23
Breast differentiation and its implication in cancer prevention. Clin Cancer Res (2005) 1.23
Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer (2006) 1.22
Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs? Breast Cancer Res Treat (2005) 1.21
Identification of cripto-1 as a novel serologic marker for breast and colon cancer. Clin Cancer Res (2006) 1.18
Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Res (2010) 1.18
Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim Biophys Acta (2009) 1.17
Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev (2008) 1.15
Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev (2006) 1.12
Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol (2008) 1.12
The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol (2005) 1.12
Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia (2011) 1.11
The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci (2006) 1.08
17Beta-estradiol is carcinogenic in human breast epithelial cells. J Steroid Biochem Mol Biol (2002) 1.05
Epithelial mesenchymal transition during the neoplastic transformation of human breast epithelial cells by estrogen. Int J Oncol (2007) 1.05
Genomic signature induced by pregnancy in the human breast. Int J Oncol (2006) 1.04
Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann N Y Acad Sci (2009) 1.04
Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Int J Cancer (2007) 1.00
Exposure to the Endocrine Disruptor Bisphenol A Alters Susceptibility for Mammary Cancer. Horm Mol Biol Clin Investig (2011) 1.00
Genotoxicity of steroidal estrogens. Trends Endocrinol Metab (2004) 1.00
17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis (2003) 1.00
Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta (2005) 0.99
Defining the genomic signature of the parous breast. BMC Med Genomics (2012) 0.97
Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause (2008) 0.97
Breast development, hormones and cancer. Adv Exp Med Biol (2008) 0.96
S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. Oncol Rep (2006) 0.94
In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: an experimental study in rats. Environ Health (2011) 0.94
ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Biochim Biophys Acta (2007) 0.93
Re: The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst (2010) 0.92
Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens. Environ Mol Mutagen (2002) 0.92
Expression pattern of a homeotic gene, HOXA5, in normal breast and in breast tumors. Cell Oncol (2006) 0.91
DNA methylation changes in a human cell model of breast cancer progression. Mutat Res (2010) 0.91
Proteomic analysis in mammary glands of rat offspring exposed in utero to bisphenol A. J Proteomics (2010) 0.90
Characterization of a genomic signature of pregnancy identified in the breast. Cancer Prev Res (Phila) (2011) 0.89
Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations. Cancer Res (2011) 0.88
Alternately spliced luteinizing hormone/human chorionic gonadotropin receptor mRNA in human breast epithelial cells. Int J Oncol (2002) 0.87
Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. Int J Oncol (2004) 0.85
The plasticizer butyl benzyl phthalate induces genomic changes in rat mammary gland after neonatal/prepubertal exposure. BMC Genomics (2007) 0.85
Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol (2012) 0.84
Role of the estrogen antagonist ICI 182,780 in vessel assembly and apoptosis of endothelial cells. Ultrastruct Pathol (2003) 0.84
An in vitro-in vivo model of epithelial mesenchymal transition in triple negative breast cancer. Drug Discov Today Dis Mech (2012) 0.83
Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol a and genistein. J Nutr (2012) 0.83
Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas. Breast Cancer Res Treat (2010) 0.83
Pregnancy-induced chromatin remodeling in the breast of postmenopausal women. Int J Cancer (2012) 0.83
Genetic identification of distinct loci controlling mammary tumor multiplicity, latency, and aggressiveness in the rat. Mamm Genome (2006) 0.82
Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res (2007) 0.82
Methodological approach to study the genomic profile of the human breast. Int J Oncol (2007) 0.82
The genomic signature of breast cancer prevention. Recent Results Cancer Res (2007) 0.82
Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 beta-estradiol in human breast epithelial cells. Cell Biol Int (2009) 0.81
The role of the basal stem cell of the human breast in normal development and cancer. Adv Exp Med Biol (2011) 0.81
CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma. Drug Metab Dispos (2008) 0.81
Difference in gene expression profile in breast epithelial cells from women with different reproductive history. Int J Oncol (2003) 0.81
The mismatch repair gene hPMS2 is mutated in primary breast cancer. Int J Mol Med (2006) 0.80
Modulating the strength of cadherin adhesion: evidence for a novel adhesion complex. J Cell Sci (2005) 0.80
The breast of parous women without cancer has a different genomic profile compared to those with cancer. Int J Oncol (2007) 0.79
DNA content and cell number determination in microdissected samples of breast carcinoma in situ. Int J Oncol (2002) 0.79
DNA content and chromatin texture of human breast epithelial cells transformed with 17-beta-estradiol and the estrogen antagonist ICI 182,780 as assessed by image analysis. Mutat Res (2007) 0.79
Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites. Int J Oncol (2005) 0.79
Inappropriate P-cadherin expression in the mouse mammary epithelium is compatible with normal mammary gland function. Differentiation (2003) 0.79
Image analysis of the AgNOR response in ras-transformed human breast epithelial cells. Acta Histochem (2007) 0.78
Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells. In Vitro Cell Dev Biol Anim (2014) 0.78
S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retroviral construct. Oncol Rep (2007) 0.78
Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells. Int J Oncol (2003) 0.78